Group items matching

in title, tags, annotations or url

Rotavirus Vaccine in developing countries have been tailored according to the conditions. Heat-Stabilty, Easy administration, and cost of goods are some ke factors taken into account.

PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).

PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.

PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).

US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.

Is it true that truly you are aware of the way that the 12 percent of all Americans who experience the evil impacts of endless sicknesses or ailments are solely accountable for a gigantic 75 percent of most of the human administrations costs in the entire United States?

Nebido is a long ester based testosterone compound which is primarily used to treat low testosterone. It is an injectable testosterone hormone that carries a long lasting activity time of post administration. Nebido is a new kind of anabolic steroid that came into the market in 2004.